Cinctive Capital Management LP Pulmonx Corp Transaction History

Cinctive Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $1.12 Million - $2.24 Million	-79,997 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $466,973 - $787,865	22,100 Added 38.17%	79,997 $1.99 Million
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $145,301 - $220,493	4,889 Added 9.22%	57,897 $1.86 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $1.52 Million - $1.87 Million	42,109 Added 386.36%	53,008 $1.91 Million
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $409,911 - $523,152	10,899 New	10,899 $481,000

Q1 2021 May 17, 2021	SELL	$44.0 - $67.54 $1.37 Million - $2.11 Million	-31,180 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $1.23 Million - $2.15 Million	31,180 New	31,180 $2.15 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.